VOYA Investment Management
VTYX

VOYA Investment Management’s Ventyx Biosciences VTYX Stock Holding History

VOYA Investment Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,475
Closed -$158K – 2451
2025
Q4 		$158K Buy
+17,475
New +$131K ﹤0.01% 2190
2025
Q2 		– Sell
-18,078
Closed -$20.8K – 2749
2025
Q1 		$20.8K Sell
18,078
-1,130
-6% -$1.94K ﹤0.01% 2618
2024
Q4 		$42.1K Sell
19,208
-1,337
-7% -$3.03K ﹤0.01% 2705
2024
Q3 		$44.8K Sell
20,545
-51,634
-72% -$119K ﹤0.01% 2777
2024
Q2 		$167K Sell
72,179
-38,990
-35% -$162K ﹤0.01% 2531
2024
Q1 		$611K Buy
111,169
+92,217
+487% +$422K ﹤0.01% 1912
2023
Q4 		$46.8K Sell
18,952
-86,688
-82% -$823K ﹤0.01% 2857
2023
Q3 		$3.67M Sell
105,640
-25,605
-20% -$885K ﹤0.01% 1087
2023
Q2 		$4.3M Buy
131,245
+121,896
+1,304% +$4.2M ﹤0.01% 1046
2023
Q1 		$313K Hold
9,349
– – ﹤0.01% 2304
2022
Q4 		$307K Buy
9,349
+563
+6% +$16.7K ﹤0.01% 2320
2022
Q3 		$307K Buy
+8,786
New +$195K ﹤0.01% 2336

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VOYA Investment Management's VTYX Position: Q1 2026 in Review

VOYA Investment Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 17,475 shares — an estimated $158K sold.

VOYA Investment Management first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $4.3M in Q2 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • VOYA Investment Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 17,475 Ventyx Biosciences shares in Q1 2026, an estimated $158K.
  • VOYA Investment Management first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
  • VOYA Investment Management's Ventyx Biosciences position peaked at $4.3M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.